IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)
New Form 8-K - Enliven Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140285 Size: 217 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
There are no comments here yet...